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Background: Granulomatous myocarditis may present with sustained monomorphic ven-
tricular tachycardia (SMVT) in the presence of normal left ventricular ejection fraction
(LVEF), and could be mistaken for idiopathic ventricular tachycardia (IVT). The use of
cardiac imaging for diagnosis can be limited by availability and high cost. ECG is readily
available and inexpensive. Fragmented QRS (fQRS) on ECG has been found to be associated
with myocardial scar. We hypothesized that fQRS could be useful in the diagnosis of
granulomatous VT (GVT).
Methods: We compared the 12-lead ECG of 16 patients with GVT and 42 patients with IVT
who presented with SMVT.
Results: The presence of fQRS was significantly higher in the GVT group compared to the
IVT group (75% versus 19.1%, p < 0.001). The location of fQRS correlated with delayed
enhancement cardiac magnetic resonance imaging (DE-CMR) in the same segment in 4/16
patients in the GVT group. It correlated with an affected segment on either DE-CMR or
18FDG positron emission computed tomography in 4/11 patients in the GVT group who had
both imaging modality. Whenever fQRS was present in contiguous leads other than the
inferior leads, it always corresponded to an affected segment on imaging.
Conclusions: In patients presenting with SMVT and no structural heart disease, the presence
of fQRS is strongly associated with granulomatous myocarditis. fQRS on the surface ECG is
a helpful tool the presence of which should prompt a CMR for a definitive diagnosis.
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Sustained monomorphic ventricular tachycardia (SMVT) of
left ventricular origin in patients with normal left ventricular
ejection fraction (EF) is most often referred as idiopathic VT
which has a good response to antiarrhythmic or ablation
therapy.1 However, granulomatous myocarditis having a
more worrisome prognosis, can also present with SMVT and
normal EF and readily mistaken for idiopathic VT.2
Ventricular tachycardia of granulomatous origin, including
cardiac sarcoidosis, is relatively infrequent cause of SMVT and
is most definitively diagnosed by cardiac magnetic resonance
(CMR) and/or 18FDG positron emission computed tomography
(18FDG PET CT).3,4 However, use of these imaging modalities is
limited by the restricted availability and the high cost
involved. Inexpensive pre-screening of such cases for
myocardial scar consistent with granulomatous disease
would be desirable.
Fragmented QRS (fQRS) on surface electrocardiogram (ECG)
has been linked to the presence ofmyocardial scar in coronary
artery disease.5e7 ECG is a readily available and a low-cost
tool. fQRS on ECG has been found to be a marker of cardiac
involvement in patients with systemic sarcoidosis.8 As
myocardial scar is a distinguishing feature between granulo-
matous myocarditis and idiopathic VT, we hypothesized that
the fQRS would be a useful screening tool for preliminary
evaluation of SMVT patients without evident structural heart
disease.Fig. 1 e The figure shows different morphologies of
fragmented QRS as explained in the text.2. Methods
2.1. Patient selection
We screened retrospectively all patients referred for a DE-
CMR after presentation for SMVT between January 2008
and December 2011. DE-CMR was requested based on
physician discretion at the time of presentation. Patients
with history or evidence of structural heart disease
including coronary artery disease (CAD), myocardial
infarction, dilated cardiomyopathy, hypertrophic cardio-
myopathy, arrhythmogenic right ventricular cardiomyopa-
thy or EF < 50% were excluded.
Recognition of granulomatous myocarditis was based on
presence of both patchy scar on DE-CMR that did not corre-
spond to a vascular distribution and subsequent histopatho-
logical confirmation of granulomatous involvement from
sampled paracardiac lymph nodes. These patients formed the
study group. GVT patients were further classified as having
cardiac sarcoidosis if M.Tuberculosis IS6110 Polymerase Chain
Reaction and mycobacterial culture on all histopathologic
sampleswere negative. Control patients comprised thosewith
SMVT and normal DE-CMR examination.
2.2. ECG criteria for fQRS
We defined fQRS on the standard 12-lead ECG recording (high
pass filter 0.15e0.5 Hz, Low pass filter 100e150 Hz, AC filter
50 Hz, paper speed 25 mm/s, voltage 10 mm/mV) based onprevious published work.7,9 If QRS< 120 ms, fQRS was defined
as an additional R wave (R0), notching in the nadir of the S
wave, or the presence of >1 R0 in at least two contiguous ECG
leads. fQRS in presence of bundle branch block (QRS > 120ms)
was defined by the presence of >2 R0 or >2 notches in the R
wave or >2 notches in the nadir of S wave in at least two
contiguous leads.We excluded an RSR0 pattern in V1-V2 in the
presence of complete or incomplete right bundle branch block
and an RSR0 pattern in I-V5-V6 in the presence of complete left
bundle branch block.
fQRS patterns present in 2 or more anatomically contig-
uous leads were assigned as follows: anterior leads (V1 to V5)
e to anterior myocardial segment, lateral leads (I, aVL, V5, and
V6) to lateral myocardial segment, and those in inferior leads
(II, III, and aVF) to inferior segment. If V1 was included in any
of the above lead combinations, we considered the septum
affected. All ECGs were reviewed by 2 independent experi-
enced readers blinded to CMR results. The agreement between
readers was 81% on the presence of notching in any single
lead and 90% on the presence of fQRS criteria. Examples of
fragmented QRS are presented in Fig. 1.2.3. Imaging
CMRwas performed using a 1.5 T scanner (Siemens, Erlangen,
Germany). Steady-state free-processing sequence and
Gradient Echo cine images were obtained in the two and four
chamber views and in the short axis every 10mm from base to
apex. Volumes and global function were derived. Delayed
enhancement (DE-CMR) was acquired starting 10 min after
gadolinium contrast administration using segmented inver-
sion recovery fast gradient echo, constantly adjusting inver-
sion time for optimum nulling of the normal myocardium.
The fasting and resting 18FDG PET CT was performed in pa-
tients with granulomatous myocarditis by employing a stan-
dard protocol previously described.102.4. Statistical analysis
Continuous variables were expressed as mean ± SD and were
compared using Student t-test. Categorical variables were
expressed as percentages and compared using chi-square test
or Fisher exact test as appropriate. All p values were 2-tailed,
with statistical significance set at 0.05 and confidence in-
tervals calculated at the 95% level. All analyses were per-
formed using JMP software version 7.0 (SAS Institute Inc.,
Cary, NC, USA).
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3.1. Patient population
Sixteen patients with evidence of granulomatous myocarditis
formed the GVT group. Forty-seven patients with SMVT and a
normal CMR exam were identified as having idiopathic VT. In
five of 47 patients the baseline ECG was not available. There-
fore, these patients were not included in the study. The
remaining 42 patients served as the Control group.
All patients presented with SMVT and were without
evident structural heart disease on preliminary evaluation. All
had LVEF of 50% or more. Each was referred for CMR based on
physician discretion. Of the 16 patients in the GVT group, 12
had confirmed cardiac sarcoid with completely negative
evaluation for tuberculosis. Four patients had confirmed
tuberculosis on PCR or culture. Demographic and electrocar-
diographic characteristics are presented in Table 1.
3.2. Electrocardiogram and fQRS
Notching or RSR0 pattern in any single lead was present in
81.2% in the GVTgroup and 50% in the Controlgroup (p ¼ 0.03).
The presence of fQRS was significantly more frequent in the
GVT group (GVT,75% versus Control, 19.1%, p < 0.001). Three
out of 4 patients (75%) with tuberculous myocarditis and 9 out
of 12 patients (75%) with cardiac sarcoid had fQRS.
3.3. Correlation of fQRS with imaging
Whenever fQRS was present in contiguous leads other than
the inferior leads, it always corresponded to an affected
segment on imaging (Table 2).
The location of a solitary lead fQRS correlatedwith CMR-DE
in the same segment in only 4/16(25%) patients in the GVT
group. Similarly solitary lead fQRS correlated with an affected
segment on either DE or PET in 4/11 (36.3%) patients in the GVT
group who had both imaging modality.
The location of fQRS, DE on CMR and inflammation on
18FDG PET CT in the different segments of LV in GVT group isTable 1 e Demographic and electrocardiographic






Age (years) 43.9 ± 8.9 43.5 ± 11.1 0.91
Male gender, n (%) 9 (56.2) 23 (54.8) 0.92
EF (%) 58.4 ± 8.3 63.7 ± 5.9 0.01
PR interval (ms) 163 ± 27 150 ± 16 0.07
PR interval > 200 ms, n (%) 2 (12.5) 0 (0) 0.07
QRS interval (ms) 99 ± 16 94 ± 11 0.19
Abnormal QRS axis, n (%) 2 (12.5) 4 (9.5) 0.66
QRS > 120 ms, n (%) 2 (12.5) 0 (0) 0.07
Presence of notching, n (%) 13 (81.2) 21 (50) 0.03
Presence of fQRS, n (%) 12 (75) 8 (19.1) <0.001
EF ¼ ejection fraction; fQRS ¼ fragmented QRS;
GVT ¼ granulomatous myocarditis related ventricular tachycardia;
IVT ¼ idiopathic ventricular tachycardia.shown in Table 2.Among the 8 patients with fQRS in the
Control group, 7 had fQRS in the inferior leads and 1 in the
lateral leads.4. Discussion
This study assessed the potential for fQRS on surface ECG to
play a role as a preliminary screening tool for identifying the
possibility that SMVT patients with apparently normal hearts
may be due to granulomatous myocarditis VT. The principal
finding was that fQRS was present in 75% of patients in whom
both imaging and histopathology confirmed the presence of
granulomatous myocarditis. The fQRS was more frequent in
GVT patients than in Controls (75% versus 19.1%. p < 0.001).
Finally, when fQRS was present in a location other than the
inferior leads, and was present in adjacent leads, there was
closer concordance with the affected myocardial segment on
imaging. On the other hand, the location of fQRS on a solitary
ECG lead did not correlate well with the location of scar or
inflammation on imaging studies.
Granulomatous myocarditis includes primarily cardiac
sarcoidosis and cardiac tuberculosis and can present with
SMVT and a preserved EF.2 Early stages of cardiac sarcoidosis
may not be detected or show non-specific findings on echo-
cardiography.11,12 Moreover, SMVT can be the primary pre-
sentation of both sarcoidosis and tuberculosis.13,14 Hence,
granulomatous myocarditis related VT can be easily mistaken
with idiopathic VT especially if no extracardiac manifesta-
tions of sarcoidosis are present.
SMVT has been found to be an independent risk factor for
mortality in patients with cardiac sarcoidosis.15 Therefore, the
early identification of this entity might have an important
impact on patient risk stratification and management.
Furthermore, disease specific therapy initiated early in the
course of the disease has been shown to decrease VT recur-
rence.2 Consequently, patients with SMVT and normal left
ventricularEF on echocardiography, and fQRS on ECG should
be investigated further to rule out granulomatous myocar-
ditis, especially in countries with higher prevalence of this
disease.
Cardiac MR and 18FDG PET CT have been increasingly used
for the diagnosis and prognostic evaluation of granulomatous
myocarditis.3,4,16 However, their use is limited by availability
and cost, especially in countries with limited resources. Elec-
trocardiogram is a readily available toolwith lowcost, and fQRS
is known to be a marker of myocardial scar, mortality and
cardiac events in patients with coronary artery disease.17 It is
also associated with increased mortality and arrhythmic
events in non-ischemic cardiomyopathyandmoreprevalent in
arrhythmogenic right ventricular cardiomyopathy (ARVC) pa-
tients.18,19 In one study, fQRS was associated with cardiac
involvement in patients with sarcoidosis.8 Our report shows
that fQRS is also associatedwith granulomatousmyocarditis in
patients with SMVT and no apparent structural heart disease.
In our study, unlike the one by Howmsiet al,20 we did not
finda correlationbetween solitary leadswith fQRSand the sites
of myocardial involvement. This, we speculate, is because of
involvement of multiple regions of the myocardium as seen in
themajority of our cases as opposed to less diffuse myocardial
Table 2 e Location of fQRS, myocardial scar and inflammation in different myocardial segments.
Column one indicates the etiology of granulomatous myocarditis in each patient. Boxes filled in blue reflect the location of fQRS on the surface
12 lead ECG as specified in the text. Boxes filled in black reflect the location of delayed enhancement. Boxes filled with gray reflect segments with
increased uptake of 18FDG.
CMR ¼ cardiac magnetic resonance; CS ¼ cardiac sarcoidosis; DE ¼ delayed gadolinium enhancement; 18FDG PET CT ¼ 18FDG positron emission
computed tomography; fQRS ¼ fragmented QRS per criteria listed in Methods section; TB ¼ tuberculosis.
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the myocardium could overlap leading to fQRS reflections in
leads not corresponding to the specific areas of myocardial
involvement. Another study of patients with CAD showed an
increase in sensitivity of fQRS for detection of scar when
analyzed independent of regional correlation.21 This means
that fQRS predicted the presence of scar on imaging, but not
necessarily in the same regional distribution.
4.1. Limitations
Our study has several limitations. First, it is a single center
retrospective studywith a small number of patients. However,
it is one of the largest series with granulomatous myocarditis
presenting with SMVT in a seemingly normal heart on pre-
liminary evaluation. Second, the ratio of patients in the GVT
group compared to the idiopathic VT patients in our study
overestimates the prevalence of granulomatous myocarditis.
This is due to the fact that only a small proportion of patients
with suspected idiopathic VT are referred for CMR, as it is
often considered unnecessary. Physicians will have a much
lower threshold to investigate a patient with history of
tuberculosis, exposure to tuberculosis, lymphadenopathy or
elevated inflammatory markers.5. Conclusion
In patients presenting with SMVT and no evident structural
heart disease on initial evaluation, the presence of fQRS onECG is strongly associated with underlying granulomatous
myocarditis, particularly cardiac sarcoid. Consequently, the
presence of fQRS on the surface ECG in such patients provides
a helpful screening tool that should prompt a CMR and other
necessary investigations for a definitive diagnosis.Funding
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